Mirus Corp.
Madison, WI 53719
Share:
Mirus Bio Awarded Broad European Patent Covering Intravascular Injection Method
MADISON, Wis., Oct. 31 - Mirus Bio Corporation announced today the grant of European Patent EP1246649 entitled Intravascular Delivery of Nucleic Acid. The patent broadly covers Pathway IV(TM), a novel method to efficiently deliver therapeutic genes to muscle and other tissues via the blood stream. This versatile platform can be used to deliver a wide range of nucleic acids, including plasmid DNA...
Read More »Mirus Bio Awarded Broad European Patent Covering Intravascular Injection Method
MADISON, Wis., Oct. 31 - Mirus Bio Corporation announced today the grant of European Patent EP1246649 entitled Intravascular Delivery of Nucleic Acid. The patent broadly covers Pathway IV(TM), a novel method to efficiently deliver therapeutic genes to muscle and other tissues via the blood stream. This versatile platform can be used to deliver a wide range of nucleic acids, including plasmid DNA...
Read More »